Goldspan Health
Goldspan Health runs one plan per molecule with no tier ladder, bills every 28 days rather than monthly, and requires a lab panel it never prices.
- Semaglutide
- $229 per 28 days (a single plan; thirteen charges a year)
- Tirzepatide
- $299 per 28 days (a single plan; thirteen charges a year)
- Coverage
- All 50 states plus Washington, D.C.
- Brand-name
- Not confirmed
Weigh Goldspan Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.
Factor breakdown
Each of the six graded dimensions. See the methodology.
Strengths
- One plan per molecule with no tier ladder to read, which removes the commonest source of a misquoted price
- Sublingual full-dose and microdose lines sit alongside the injections for readers who will not inject
- States its compounding class — dispensed by a pharmacy licensed under 503A or 503B — rather than leaving it unsaid
- Names a medical director and two clinical advisors by name and specialty
- A lab panel is genuinely required at 60 to 90 days and annually after that, which is stronger monitoring than most of this ranking asks for
Where it loses points
- The required lab panel is described as available at a low cost and its cost is stated nowhere on the site
- The hero says “/month”, the plan card says billed every 28 days and the order timeline says every four weeks — thirteen charges a year, not twelve
- “Pause, delay, or cancel at any time” on the storefront sits against a refund policy reading “all sales are final” and platform terms saying an order cannot be canceled once placed
- The tirzepatide sublingual microdose page lists compounded sublingual semaglutide microdose in its own inclusion list
- Clinicians are attributed to a partner platform while the storefront states it is not a medical practice
- No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
- Full-dose sublingual products exist on the catalog and are not linked from the site's own weight-loss page
Bottom line — Grade C
Best for: Shoppers who want a single unambiguous plan per molecule and a sublingual route, and who will budget separately for the required lab panel.
Site position #169 of 542. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest Goldspan Health — the realistic shortlist.
Publishes its prices before any intake quiz — but every figure it displays is the twelve-month prepay rate, and the month-to-month price you would actually pay ($259 semaglutide, $349 tirzepatide) is printed on no page at all.
Go Vida Plena is a Spanish-first, Latino-focused medical weight-loss program offering GLP-1 therapy from $199/month, based in Utah.
Telehealth wellness clinic offering GLP-1 medications on a 4-week billing cycle.
WeightlessRx pairs three-month medication packages with nutrition coaching and clinician messaging, but monthly-billing and refund clauses need clarification before enrollment.
ElitePhysiqMD is a physician-led telehealth platform prescribing compounded semaglutide (from $145/mo) and tirzepatide (from $315/mo subscription) to patients in all 50 states.
FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).
The 20 rankings nearest this one
- #174 ReadyRx67.8
- #175 RX Bella67.8
- #176 Blue Sky MD67.7
- #177 PlexusDx67.7
- #178 Rebody Health67.7
- #179 TeleCareSpot67.7
- #180 MyFastRx67.6
- #181 OurView Health67.6
- #182 TrueMe67.6
- #183 Factor Health MD67.5
- #184 24hrDOC67.3
- #185 Nu Image Medical67.3
- #186 LillyDirect Foundayo67.2
- #187 Optimized Health67.2
- #188 Andrew Meds67.1
- #189 LeanDose67.1
- #190 Dr. Gillis' Wellness Center67
- #191 Jently67
- #192 OrderlyMeds67
- #193 Center for Medical Weight Loss (CMWL)66.9
Pricing/verification reflect Goldspan Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.